Thiamine deficiency in the critically ill
the dosage forms are all subcutaneous/intramuscular injections, and to avoid serious gastrointestinal adverse events, it is necessary to start with a low dosage and gradually increase the dosage during use
A decade later, a host of new GLP-1s and new indications for existing GLP-1s are being studied, including sleep apnea and diabetic nephropathy
Contamination: If bacteria or other contaminants enter the vial (often from improper needle technique), the liquid may become cloudy or change color
Importantly, absolute rate reductions for all effectiveness outcomes were larger with increasing severity of frailty. Researchers conducted a retrospective cohort study of older adults aged at least 65 years diagnosed with type 2 diabetes who initiated an SGLT2 inhibitor, GLP-1 receptor agonist or a DPP-IV inhibitor
Quesada A, Lee BY, Micevych PE